Skip to main content

Table 5 Characteristics of each cost-effectiveness analysis (CEA) for pressure ulcers (n = 14)

From: A systematic review of cost-effectiveness analyses of complex wound interventions reveals optimal treatments for specific wound types

CEA (Original year of values) Country (Original currency) Perspective Efficacy study design Sample size Population Timeframe Funding source a
Branom 2001 (2000) [64] USA (US$) Not reported RCT 20 Mean 72 yrs; bedridden max. 8 wks Not reported
Burgos 2000 (1998) [65] Spain (Pta) Not reported RCT 37 Mean 80 yrs 12 wks Private
Chang 1998 (1997) [66] Malaysia (RM) Not reported RCT 34 Mean 58 yrs max. 8 wks Private
Chuangsu-wanich 2011 (2010) [67] Thailand (US$) Not reported RCT 45 Mean 66 yrs 8 wks Not reported
Ferrell 1995 (1992) [68] USA (US$) Provider RCT 84 Mean 81 yrs; mostly Caucasians; most fecal incontinence 52 wks Mixed
Foglia 2012 (2010) [69] Italy (€) Provider Observational 362 Most >80 yrs 4.3 wks Not reported
Graumlich 2003 (2001) [70] USA (US$) Not reported RCT 65 Mean 83 yrs 8 wks Public
Muller 2001 (1998) [71] The Netherlands (NLG) Provider RCT 24 Mean 73 yrs; all females 12 wks Private
Narayanan 2005 (2004) [72] USA (US$) Not reported Observational 976 Most ≥80 yrs; mostly Caucasians approx. 22 wks  
Payne 2009 (2007) [73] USA (US$) Provider RCT 36 Mean 73 yrs 4 wks Private
Robson 2000 (1999) [74] USA (US$) Not reported RCT 61 Mean 50 yrs; mostly Caucasians 5 wks Mixed
Sanada 2010 (2007) [75] Japan (Yen) Not reported Observational 105 Mean 75 yrs 3 wks Not reported
Xakellis 1992 (1990) [76] USA (US$) Not reported RCT 39 Mean 80 yrs 1.4 wks Mixed
Seberrn 1986 (1985) [77] USA (US$) Not reported RCT 77 Mean 74 yrs 8 wks Not reported
  1. RCT, Randomized clinical trial; SR, Systematic review; wks, Weeks; yrs, Years.
  2. aMixed here indicates both private and public funding.